| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |